Lunai Bioworks Inc. Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage
Lunai Bioworks Inc. (LNAI) had Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage of 100.00% as of 2014-02-12, per its 10-Q filed 2014-11-13.
Discontinued › Notes
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage · last filed 2014-11-13
- 2014-02-12: Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage 100.00%.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage |
|---|---|
| 2014-02-12 | 100.00% 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |